STR Webinar: Understanding U.S. Customs Valuation in the Biopharma and Life Sciences Industry
Biopharma and life sciences companies face unique challenges when valuing their research and development, clinical, commercial, and compassionate use products for cross-border transactions. These valuation decisions - which can have significant impacts on the amount of duties and tariffs owed, particularly in today’s volatile trade policy environment - must also comply with U.S. customs and tax laws while complementing the company’s business and tax strategies.